| dc.contributor.author |
Brunner, C |
en |
| dc.contributor.author |
Kanellos, T |
en |
| dc.contributor.author |
Meli, M |
en |
| dc.contributor.author |
Sutton, D |
en |
| dc.contributor.author |
Gisler, R |
en |
| dc.contributor.author |
Gomes-Keller, M |
en |
| dc.contributor.author |
Hofmann-Lehmann, R |
en |
| dc.contributor.author |
Lutz, H |
en |
| dc.date.accessioned |
2014-06-06T06:46:52Z |
|
| dc.date.available |
2014-06-06T06:46:52Z |
|
| dc.date.issued |
2006 |
en |
| dc.identifier.uri |
http://dx.doi.org/10.1016/j.vaccine.2005.10.030 |
en |
| dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/3253 |
|
| dc.subject |
Modified Live Virus |
en |
| dc.subject |
Specific Pathogen Free |
en |
| dc.title |
Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component |
en |
| heal.type |
journalArticle |
en |
| heal.identifier.primary |
10.1016/j.vaccine.2005.10.030 |
en |
| heal.publicationDate |
2006 |
en |
| heal.abstract |
The compatibility, safety and interaction on antibody induction of a combined vaccine application were assessed. Specific pathogen-free cats were vaccinated with either a modified live virus vaccine containing feline calici- (FCV), herpes- (FHV-1), parvovirus (FPV) and Chlamydophila felis (C. felis), an adjuvanted recombinant feline leukaemia virus (FeLV) vaccine or both vaccines in one syringe. After combined application, FeLV ELISA antibody |
en |
| heal.journalName |
Vaccine |
en |
| dc.identifier.doi |
10.1016/j.vaccine.2005.10.030 |
en |